EDITORIAL
Published on 25 Jan 2023
Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
doi 10.3389/fonc.2023.1138587
- 953 views
- 2 citations
- Frontiers in Oncology
- Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
- Research Topics
- Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer
Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer
4,773
Total downloads
12k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 20 Sep 2022
Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
doi 10.3389/fonc.2022.945829
- 1,405 views
- 4 citations
ORIGINAL RESEARCH
Published on 18 Aug 2022
Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer
doi 10.3389/fonc.2022.879661
- 2,689 views
- 3 citations
REVIEW
Published on 16 Jun 2022
Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
doi 10.3389/fonc.2022.828223
- 2,293 views
- 5 citations
CASE REPORT
Published on 06 Jun 2022
Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer
doi 10.3389/fonc.2022.898119
- 1,800 views
- 3 citations
